Latest filing published 10 Nov 2020 for Enovis CORP, €28k.
Filing timeline
BuySaleInsider track record
Jason MacLean: trading record in brief
Jason MacLean discloses dealings in Enovis Corp to SEC (Form 4). In total, 6 filings cover trades dated from 7 November 2017 to 9 November 2020.
No open-market purchase appears, only 4 sales worth €166k. Outside the open market, there are 2 share grants. In 2020 alone, the filings show no purchases and 2 sales.
The newest entry dates from 10 November 2020: an open-market sale of €28k, in Enovis Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jason MacLean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,001 shares@ US$33.1127.2% of flowCommon stock, par value $.001SEC:0001209191-20-057794:0
- 2,491 shares@ US$35.3254.3% of flowCommon stock, par value $.001SEC:0001209191-20-046672:0
- 2,715 shares0Common Stock, par value $.001SEC:0001209191-20-013179:0
- 1,125 shares@ US$34.1721.0% of flowCommon Stock, par value $.001SEC:0001209191-19-056060:0
- 1,120 shares@ US$29.0617.2% of flowCommon Stock, par value $.001SEC:0001209191-18-057959:0
- 10,836 shares0Common Stock, par value $.001SEC:0001209191-17-060001:0
6 of 6 declarations
